Evidence map›Paper›PMID 33254580›Full record

ArticleMedical hypotheses2020

Periodontal disease and targeted prevention using aMMP-8 point-of-care oral fluid analytics in the COVID-19 era.

Ismo T Räisänen, Kehinde A Umeizudike, Pirjo Pärnänen, Pia Heikkilä, Taina Tervahartiala, Solomon O Nwhator, Andreas Grigoriadis, Dimitra Sakellari, Timo Sorsa

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Medical hypotheses, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05950230 (A Case-Control Study on the Association Between Periodontal Health and Gingival Crevicular Level of Matrix Metalloproteinase-8 in Post COVID-19 Patients), which is not on this map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05950230 unknown statusnot on this mapstarted 2023, after this paper: background citation

A Case-Control Study on the Association Between Periodontal Health and Gingival Crevicular Level of Matrix Metalloproteinase-8 in Post COVID-19 Patients

TypeobservationalSponsorAin Shams UniversityRan2023 to 2023Enrolled90ConditionsPost COVID-19 ConditionArmsAssess Periodontal Health Status, Collecte GCF samples by paperstrip
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Importance of Metalloproteinase 8 (MMP-8) in the Diagnosis of Periodontitis.International journal of molecular sciences · 2024
    Review
  2. Article
  3. Article
  4. Article
  5. Periodontal disease and COVID-19: Prognosis and potential pathways of association in their pathogenesis.Canadian journal of dental hygiene : CJDH = Journal canadien de l'hygiene dentaire : JCHD · 2023
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Periodontal Diseases and COVID-19: A Scoping Review.European journal of dentistry · 2021
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 4 countries.

Ismo T RäisänenDepartment of Oral and Maxillofacial Diseases, Helsinki University and University Hospital, Helsinki, Finland. Electronic address: ismo.raisanen@helsinki.fi.
Kehinde A UmeizudikeDepartment of Preventive Dentistry, Faculty of Dental Sciences, College of Medicine, University of Lagos, Lagos, Nigeria.
Pirjo PärnänenDepartment of Oral and Maxillofacial Diseases, Helsinki University and University Hospital, Helsinki, Finland.
Pia HeikkiläDepartment of Oral and Maxillofacial Diseases, Helsinki University and University Hospital, Helsinki, Finland.
Taina TervahartialaDepartment of Oral and Maxillofacial Diseases, Helsinki University and University Hospital, Helsinki, Finland.
Solomon O NwhatorDepartment of Preventive and Community Dentistry, Obafemi Awolowo University, Ile-Ife, Nigeria.
Andreas GrigoriadisDepartment of Periodontology, 424 General Army Hospital, Thessaloniki, Greece; Department of Preventive Dentistry, Periodontology, and Implant Biology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Dimitra SakellariDepartment of Preventive Dentistry, Periodontology, and Implant Biology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Timo SorsaDepartment of Oral and Maxillofacial Diseases, Helsinki University and University Hospital, Helsinki, Finland; Department of Oral Diseases, Karolinska Institutet, Huddinge, Sweden.
University of Helsinki · FI424 General Military Hospital · GRAristotle University of Thessaloniki · GRKarolinska Institutet · SEObafemi Awolowo University · NGUniversity of Lagos · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Periodontal disease is a chronic multifactorial infectious and inflammatory disease associated with several chronic systemic diseases, such as diabetes, cardiovascular diseases (CVD), chronic obstructive pulmonary disease, hypertension, Alzheimer's disease and so on. These same systemic diseases have been associated with severe COVID-19 infections. Several recent studies have suggested hypotheses for the potential association between periodontal disease and severe COVID-19. Periodontal disease is also one of the most prevalent diseases globally. All this supports the importance of good oral health, also in the COVID-19 era. Thus, new strategies and approaches to identify patients at risk of periodontal disease could be beneficial to enhance secondary prevention, especially if targeted to COVID-19 risk groups. Diagnostic biomarkers for periodontal disease have been researched extensively. Potential biomarkers in oral fluid with currently available rapid non-invasive point-of-care technology, such as aMMP-8, could help to extend screening and identification of patients at risk for periodontal disease also to situations and places where professional dental expertise and equipment are limited or unavailable. i.e., nursing and care homes, and rural and distant places. The oral fluid point-of-care technologies could also be useful in the hands of medical professionals (diabetes, CVD, etc.) to identify patients at risk for undiagnosed periodontal disease and to refer them to a dentist for examination and evaluation. Finally, if there is a causality between periodontal disease and severe COVID-19 infections, these point-of-care oral fluid biomarker technologies could possibly also help in the assessment of the risk of deterioration and complications.

Indexed as

Point-of-Care TestingAdministration, OralBiomarkersCOVID-19Health Services AccessibilityHumansMatrix Metalloproteinase 8Models, TheoreticalMouthwashesOral HealthPeriodontitisPoint-of-Care SystemsRiskSecondary PreventionSeverity of Illness IndexTelemedicineBiomarkersMatrix Metalloproteinase 8MMP8 protein, humanMouthwashesaMMP-8COVID-19PeriodontitisPoint-of-care testingPreventionTeledentistry

Identifiers

PMID33254580
PMCPMC7492808
OpenAlexW3084842346

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.